STRATA Skin Sciences Inc (SSKN)

Currency in USD
1.2200
-0.0600(-4.69%)
Closed·
1.22000.0000(0.00%)
·
SSKN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.21001.3050
52 wk Range
1.19003.8600
Key Statistics
Prev. Close
1.22
Open
1.305
Day's Range
1.21-1.305
52 wk Range
1.19-3.86
Volume
100.5K
Average Volume (3m)
2.27M
1-Year Change
-57.64%
Book Value / Share
0.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SSKN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.4000
Upside
+506.56%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

STRATA Skin Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

STRATA Skin Sciences Inc Company Profile

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.

STRATA Skin Sciences Inc Earnings Call Summary for Q3/2025

  • STRATA Skin Sciences reported Q3 2025 revenue of $6.9M, down 20% YoY, with a $1.6M net loss, triggering an 8.93% stock price drop in aftermarket trading.
  • Equipment revenue plunged 60% YoY while global recurring revenue increased 3%, with the company maintaining a slightly positive adjusted EBITDA.
  • Management secured $2.2M through a direct offering, ending the quarter with $7.1M in cash and cash equivalents.
  • CEO Dr. Dolev Rafaeli forecasts a 'seasonally stronger' Q4 2025, with plans to deploy 200 TheraClearX devices by year-end.
  • The company anticipates growth from expanded CPT codes effective January 2027, which will broaden reimbursement eligibility for excimer laser treatments.
Last Updated: 2025-11-13, 05:30 p/m
Read Full Transcript

Compare SSKN to Peers and Sector

Metrics to compare
SSKN
Peers
Sector
Relationship
P/E Ratio
−0.7x−4.7x−0.6x
PEG Ratio
−4.430.030.00
Price/Book
5.5x3.0x2.6x
Price / LTM Sales
0.2x3.1x3.2x
Upside (Analyst Target)
-51.9%41.8%
Fair Value Upside
Unlock15.3%5.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.4000
(+506.56% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy4.00+227.87%6.00MaintainAug 14, 2025
Maxim Group
Buy6.00+391.80%-New CoverageFeb 27, 2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.36 / 0.03
Revenue / Forecast
6.93M / 11.53M
EPS Revisions
Last 90 days

SSKN Income Statement

People Also Watch

0.46
VSEE
+4.49%
0.5740
ASNS
-2.53%
4.9900
BBGI
-3.29%
0.583
VCIG
+0.52%

FAQ

What Is the STRATA Skin Sciences (SSKN) Stock Price Today?

The STRATA Skin Sciences stock price today is 1.2200

What Stock Exchange Does STRATA Skin Sciences Trade On?

STRATA Skin Sciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for STRATA Skin Sciences?

The stock symbol for STRATA Skin Sciences is "SSKN."

What Is the STRATA Skin Sciences Market Cap?

As of today, STRATA Skin Sciences market cap is 7.18M.

What Is STRATA Skin Sciences's Earnings Per Share (TTM)?

The STRATA Skin Sciences EPS (TTM) is -2.56.

From a Technical Analysis Perspective, Is SSKN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has STRATA Skin Sciences Stock Split?

STRATA Skin Sciences has split 3 times.

How Many Employees Does STRATA Skin Sciences Have?

STRATA Skin Sciences has 106 employees.

What is the current trading status of STRATA Skin Sciences (SSKN)?

As of Dec 24, 2025, STRATA Skin Sciences (SSKN) is trading at a price of 1.2200, with a previous close of 1.2200. The stock has fluctuated within a day range of 1.2100 to 1.3050, while its 52-week range spans from 1.1900 to 3.8600.

What Is STRATA Skin Sciences (SSKN) Price Target According to Analysts?

The average 12-month price target for STRATA Skin Sciences is USD7.4, with a high estimate of USD10.8 and a low estimate of USD4. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +506.56% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.